• Cloud DX (CDX) and partner Medtronic Canada ULC have signed their first joint Remote Patient Monitoring contract
  • This contract marks the first joint deployment for Cloud DX and Medtronic since their announcement of a strategic collaboration
  • The program will support pulmonary COPD rehab patients with online education and rehab therapy sessions at St. Mary’s General Hospital in Kitchener
  • Medtronic develops and manufactures therapeutic medical devices for chronic diseases
  • Cloud DX provides a digital and virtual health care platform for patient remote monitoring
  • Cloud DX Inc. (CDX) opened trading at C$0.295 per share

Cloud DX (CDX) and partner Medtronic Canada ULC have signed their first joint Remote Patient Monitoring contract.

The contract will support Virtual Care delivery at St. Mary’s General Hospital in Kitchener, beginning with an initial deployment for the hospital’s COPD Activation Program.

The program will support pulmonary COPD rehab patients with online education and rehab therapy sessions twice a week over a four-week period.

Jessica Rudd, Director New Partnerships and Solutions at Medtronic Canada commented on the joint contract with Cloud DX.

“We are pleased to announce this traction in our partnership with Cloud DX, the first of many contracts together. In our commitment to developing the virtual healthcare pathway, we are thrilled to work with Cloud DX and innovative hospitals, such as St. Mary’s General Hospital. Virtual Care is a key component in the future of healthcare; it enhances many aspects of healthcare delivery from post-surgical support to at-home pulmonary rehab. It can bring patients and care teams closer together, improves patient outcomes, and helps to address our overloaded healthcare system. We look forward to supporting St. Mary’s in delivering these benefits and growing our relationship together.”

Robert Kaul, CEO and Founder of Cloud DX added,

“As a Kitchener based MedTech company, it is exciting to support a local hospital. With St. Mary’s we will begin with the COPD Activation Program. This innovative program will offer online education and therapy sessions all via our Connected Health™ platform. It is clear this partnership between two renowned providers of healthcare services is an indication of things yet to come – especially when looking into how much more Virtual Care we can expect moving forward.”

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools.

Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care.

Cloud DX Inc. (CDX) opened trading at C$0.295 per share.

More From The Market Online

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.